Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jin Zhang, Chuang Wan, Bo Yu, Chen Gao, Liqun Zhao, Xin Cheng, Feng Yang, Hao Gu, Quanming Zou, Jiang Gu & Xingyong Wang. (2019) Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by Pseudomonas aeruginosa. Human Vaccines & Immunotherapeutics 15:12, pages 2993-3002.
Read now
Read now
Andreas H. Laustsen. (2019) How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?. Expert Opinion on Drug Discovery 14:11, pages 1103-1112.
Read now
Read now
Giovanni Cammarota, Antonella Gallo, Gianluca Ianiro & Massimo Montalto. (2019) Emerging drugs for the treatment of clostridium difficile. Expert Opinion on Emerging Drugs 24:1, pages 17-28.
Read now
Read now
Articles from other publishers (22)
Joshua Heuler, Harish Chandra & Xingmin Sun. (2023) Mucosal Vaccination Strategies against Clostridioides difficile Infection. Vaccines 11:5, pages 887.
Crossref
Crossref
Artem A. Derkaev, Ekaterina I. Ryabova, Ilias B. Esmagambetov, Dmitry V. Shcheblyakov, Svetlana A. Godakova, Irina D. Vinogradova, Anatoly N. Noskov, Denis Y. Logunov, Boris S. Naroditsky & Alexander L. Gintsburg. (2022) rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis. Frontiers in Microbiology 13.
Crossref
Crossref
Melanie L. Hyte, Lee J. Arphai, Charles J. Vaughn & Spencer H. Durham. (2022) The Role of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infections: A Review of the Current Literature and Paradigm Shift after 2021. Antibiotics 11:9, pages 1211.
Crossref
Crossref
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2022) Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective. Frontiers in Immunology 13.
Crossref
Crossref
Hui Wang, Daijie Chen & Huili Lu. (2022) Anti-bacterial monoclonal antibodies: next generation therapy against superbugs. Applied Microbiology and Biotechnology 106:11, pages 3957-3972.
Crossref
Crossref
Sheo B. Singh, Lynn Miesel, Susanne Kramer, Libo Xu, Fangbio Li, Jing Lan, Phillip Lipari, Jon D. Polishook, Gongjie Liu, Lianzhu Liang & Amy M. Flattery. (2022)
Nocathiacin, Thiazomycin, and Polar Analogs Are Highly Effective Agents against Toxigenic
Clostridioides difficile
. Journal of Natural Products 85:4, pages 1141-1146.
Crossref
Crossref
Avia Watson, Harsh Maan, Ilana Kolodkin-Gal & Natalia T. Freund. 2022. Antibiofilm Strategies. Antibiofilm Strategies
263
298
.
Britt Nibbering, Dale N. Gerding, Ed J. Kuijper, Romy D. Zwittink & Wiep Klaas Smits. (2021) Host Immune Responses to Clostridioides difficile: Toxins and Beyond. Frontiers in Microbiology 12.
Crossref
Crossref
Raysa Rosario-Acevedo, Sergei S. Biryukov, Joel A. Bozue & Christopher K. Cote. (2021) Plague Prevention and Therapy: Perspectives on Current and Future Strategies. Biomedicines 9:10, pages 1421.
Crossref
Crossref
Liubov Yakovlieva, Julius A. Fülleborn & Marthe T. C. Walvoort. (2021) Opportunities and Challenges of Bacterial Glycosylation for the Development of Novel Antibacterial Strategies. Frontiers in Microbiology 12.
Crossref
Crossref
Marco Terreni, Marina Taccani & Massimo Pregnolato. (2021) New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Molecules 26:9, pages 2671.
Crossref
Crossref
Daisuke Oka, Naomitsu Yamaya, Takuya Kuno, Yuta Asakawa, Toshiyuki Shiragiku, Liang Chen, Jingbo Xue, Abudusaimi Mamuti, Fangguo Ye, Jiangqin Sun, Kinue Ohguro, Hisashi Miyamoto, Yukitaka Uematsu, Katsuya Inagaki, Jie-Fei Cheng & Makoto Matsumoto. (2021)
In Vitro
and
In Vivo
Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile
. Antimicrobial Agents and Chemotherapy 65:4.
Crossref
Crossref
Carine A. Nkemngong, Gurpreet K. Chaggar, Xiaobao Li, Peter J. Teska & Haley F. Oliver. (2020) Disinfectant wipes transfer Clostridioides difficile spores from contaminated surfaces to uncontaminated surfaces during the disinfection process. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
J. Pollock, A.S. Low, R.E. McHugh, A. Muwonge, M.P. Stevens, A. Corbishley & D.L. Gally. (2020) Alternatives to antibiotics in a One Health context and the role genomics can play in reducing antimicrobial use. Clinical Microbiology and Infection 26:12, pages 1617-1621.
Crossref
Crossref
Shashi B. Kumar, Shanvanth R. Arnipalli & Ouliana Ziouzenkova. (2020) Antibiotics in Food Chain: The Consequences for Antibiotic Resistance. Antibiotics 9:10, pages 688.
Crossref
Crossref
Felix Broecker, Erik Wegner, Bruna M. S. Seco, Paulina Kaplonek, Maria Bräutigam, Armin Ensser, Frederick Pfister, Christoph Daniel, Christopher E. Martin, Jochen Mattner & Peter H. Seeberger. (2019)
Synthetic Oligosaccharide-Based Vaccines Protect Mice from
Clostridioides difficile
Infections
. ACS Chemical Biology 14:12, pages 2720-2728.
Crossref
Crossref
Ana Paula Guedes Frazzon, Michele Bertoni Mann & Jeverson Frazzon. 2019. Antibiotic Drug Resistance. Antibiotic Drug Resistance
477
502
.
Yan A. Ivanenkov, Renat S. Yamidanov, Ilya A. Osterman, Petr V. Sergiev, Andrey A. Ayginin, Vladimir A. Aladinskiy, Anastasia V. Aladinskaya, Victor A. Terentiev, Mark S. Veselov, Dmitry A. Skvortsov, Katerina S. Komarova, Alexey V. Chemeris, Liana F. Zainullina, Marina A. Maximova, Zulfiya R. Zileeva, Yulia V. Vakhitova, Alexey Kh. Baymiev, Andrey Kh. Baymiev, Alina A. Sofronova, Alexey E. Machulkin, Rostislav A. Petrov, Dmitry S. Bezrukov, Maria M. Puchinina, Dmitrii A. Lukianov & Olga A. Dontsova. (2019) Substituted Furanocoumarins as Novel Class of Antibacterial Translation Inhibitors. Combinatorial Chemistry & High Throughput Screening 22:6, pages 400-410.
Crossref
Crossref
Hemangi B. Shah, Kenneth Smith, Jonathan D. Wren, Carol F. Webb, Jimmy D. Ballard, Rebecka L. Bourn, Judith A. James & Mark L. Lang. (2019) Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Frontiers in Immunology 9.
Crossref
Crossref
Viola Fühner, Philip Alexander Heine, Saskia Helmsing, Sebastian Goy, Jasmin Heidepriem, Felix F. Loeffler, Stefan Dübel, Ralf Gerhard & Michael Hust. (2018) Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile. Frontiers in Microbiology 9.
Crossref
Crossref
Séverine Péchiné, Jean F. Bruxelle, Claire Janoir & Anne Collignon. (2018) Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection. Frontiers in Microbiology 9.
Crossref
Crossref
Saša Jaćović, Slobodan Milisavljević, Miloš Milosavljević, Slobodan Janković & Srđan Stefanović. (2018) Modern approach to the therapy of infections caused by Clostridium difficile. Racionalna terapija 10:2, pages 25-31.
Crossref
Crossref